Interleukin-5 Antagonist
DBCAT003472Therapeutic category
A DrugBank category of 3 drugs. 3 of them are approved.
- Also known as
- Interleukin-5 Antagonists
What you can answer from here — as of October 03, 2019
Which targets do Interleukin-5 Antagonist share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account